{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&max-date=2014-10-27", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health&max-date=2014-10-27", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&max-date=2014-10-27&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=0&max-date=2014-10-27", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&max-date=2014-10-27", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&max-date=2014-10-27", "items" : [{"_about" : "http://data.parliament.uk/resources/100977", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/100977/answer", "answerText" : {"_value" : "
The Drug Tariff sets out what National Health Service dispensing contractors will be paid for the products supplied as part of providing pharmaceutical services and the fees for providing those services in primary care.<\/p>
<\/p>
<\/p>
<\/p>
The current arrangements in the Drug Tariff for paying for specials were introduced in 2011. The Drug Tariff sets the price that the NHS pays to dispensing contractors for dispensing some of the most popular specials. Setting a reimbursement price encourages dispensing contractors to obtain best value for the NHS while also ensuring patients received the medicines they need, when they need them. The products listed and their reimbursement prices are agreed with the Pharmaceutical Services Negotiating Committee and reviewed regularly. However, due to the number of specials that can potentially be prescribed, it is not possible to list a reimbursement price for all available specials.<\/p>
<\/p>
<\/p>
<\/p>
Where the reimbursement price of a product has not been set, dispensing contractors are paid according to how the product is sourced. Where a dispensing contractor buys the product from a specials manufacturer or an importer, they must claim the invoice price of the pack size used to dispense the product minus any discounts or rebates received.<\/p>
<\/p>
<\/p>
<\/p>
NHS England is responsible for commissioning pharmaceutical services in primary care and it is for NHS England to consider whether dispensing contractors have acted appropriately. In addition, the General Pharmaceutical Council is responsible for regulating the pharmacy professions should there be any concerns of professional misconduct.<\/p>
<\/p>
<\/p>
<\/p>
Many hospital pharmacies manufacture their own specials on the premises. Any procurement of unlicensed medicines via framework agreements for the use of NHS secondary care establishments in England is undertaken through tenders governed by the Public Contracts Regulations (2006), as amended, which require the procurement to be conducted in a transparent and equitable manner.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"} } , "answeringMemberPrinted" : {"_value" : "Earl Howe"} , "dateOfAnswer" : {"_value" : "2014-11-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-11-10T14:29:40.6106923Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what safeguards exist to ensure that the pricing of \"specials\" drugs prescribed within the National Health Service is consistent and non-discriminatory, including when prescribed by general practitioners.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2037", "label" : {"_value" : "Biography information for Lord Lester of Herne Hill"} } , "tablingMemberPrinted" : [{"_value" : "Lord Lester of Herne Hill"} ], "uin" : "HL2433"} , {"_about" : "http://data.parliament.uk/resources/101009", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/101009/answer", "answerText" : {"_value" : "
General Practitioner (GP) income is made up of global sum payments for carrying out essential and additional services under the contract. Practices may also receive further payments for specific services including:<\/p>
<\/p>
<\/p>
<\/p>
- enhanced services \u2013 those that require an enhanced level of service provision above what is required under the core contract. The additional payment for diagnosing dementia falls within this category; and<\/p>
<\/p>
<\/p>
<\/p>
- the quality and outcomes framework (QOF) - a voluntary incentive scheme that provides payment to GP practices for how well they care for patients based on performance against a number of agreed indicators.<\/p>
<\/p>
<\/p>
<\/p>
Specifically on diagnosis, a number of QOF indicators are concerned with the establishment of disease registers. In order to receive payment GPs are required to ensure diagnosis levels consistent with those expected for their population for the following conditions:<\/p>
<\/p>
<\/p>
<\/p>
- atrial fibrillation;<\/p>
<\/p>
- coronary heart disease;<\/p>
<\/p>
- heart failure;<\/p>
<\/p>
- hypertension;<\/p>
<\/p>
- peripheral arterial disease;<\/p>
<\/p>
- stroke and trans-ischaemic attack;<\/p>
<\/p>
- diabetes mellitus;<\/p>
<\/p>
- hypothyroidism;<\/p>
<\/p>
- asthma;<\/p>
<\/p>
- chronic obstructive pulmonary disease;<\/p>
<\/p>
- dementia;<\/p>
<\/p>
- depression;<\/p>
<\/p>
- schizophrenia, bipolar affective disorder and other psychoses and other patients on lithium therapy;<\/p>
<\/p>
- cancer;<\/p>
<\/p>
- chronic kidney disease;<\/p>
<\/p>
- epilepsy;<\/p>
<\/p>
- osteoporosis;<\/p>
<\/p>
- rheumatoid arthritis; and<\/p>
<\/p>
- obesity.<\/p>
<\/p>
<\/strong><\/p> <\/p> <\/p> <\/p> Each year NHS Employers, on behalf of NHS England, negotiates the new GP contract with the General Practitioners Council of the British Medical Association. This includes discussion of changes to the Enhanced Services and QOF.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"}
}
, "answeringMemberPrinted" : {"_value" : "Earl Howe"}
, "dateOfAnswer" : {"_value" : "2014-11-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-05T12:10:48.5057659Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "General Practitioners: Pay"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty\u2019s Government, further to the announcement by NHS England that general practitioners are to be paid an additional £55 for diagnosing dementia in patients, what other complaints or illnesses diagnosed by general practitioners are already rewarded by payments additional to their salaries; and whether they will review the system of additional payments of this sort.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/950", "label" : {"_value" : "Biography information for Lord Stoddart of Swindon"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Stoddart of Swindon"}
], "uin" : "HL2465"}
, {"_about" : "http://data.parliament.uk/resources/101109", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/101109/answer", "answerText" : {"_value" : " A modernised Nursery Milk Scheme is currently under development and expected to be tendered in due course.<\/p> <\/p> <\/p> <\/p> The assessment of any effects of the changes to the Nursery Milk Scheme are part of ongoing discussions between officials via a cross Government Nursery Milk Scheme Task and Finish Group.<\/p> <\/p> <\/p> <\/p> The changes have no impact on either the current School Food Standards Regulations or the new School Food Standards Regulations which come into force on 1 January 2015.<\/p> <\/p> <\/p> <\/p> The Nursery Milk Scheme is available to all children under five who attend an eligible childcare setting for two hours per day or more. Eligible settings include child-minders, day care providers, private and local authority run nurseries. The School Food Standards apply to schools rather than nursery and private childcare and child minder settings.<\/p> <\/p> <\/p> <\/p> <\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2014-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-03T16:47:01.6336002Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "School Milk"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment she has made of the effect of recent changes to the nursery milk scheme on the ability of schools to fulfil the requirements of the School Food Standards in relation to milk.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4012", "label" : {"_value" : "Biography information for Graeme Morrice"}
}
, "tablingMemberConstituency" : {"_value" : "Livingston"}
, "tablingMemberPrinted" : [{"_value" : "Graeme Morrice"}
], "uin" : "212127"}
, {"_about" : "http://data.parliament.uk/resources/101140", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/101140/answer", "answerText" : {"_value" : " The Department is continuing negotiations for the supply of the meningococcal B vaccine Bexsero®<\/sup> with the manufacturer Novartis.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-30T17:10:17.0276Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Meningitis: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 5 September 2014 to Question 207051, whether a price for the meningitis B vaccine has been agreed with the manufacturer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "212038"}
, {"_about" : "http://data.parliament.uk/resources/101141", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/101141/answer", "answerText" : {"_value" : " Public Health England (PHE) are reviewing the details of the guidance recently published by Center for Disease Control and Prevention (CDC) to identify any elements of good practice that should be considered for introduction into the United Kingdom. Initial reviews of the information that we have received so far suggest that the CDC and PHE guidance are functionally comparable.<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-30T17:11:50.5706258Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Ebola"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, with reference to the decision by the Center for Disease Control and Prevention to tighten infection control guidance for US healthcare settings, what steps he has taken to revise guidance for health workers on caring for patients for Ebola.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "212037"}
, {"_about" : "http://data.parliament.uk/resources/101142", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/101142/answer", "answerText" : {"_value" : " Research projects on health reform were commissioned during 2007 and 2008 and brought together within the framework of the independent Health Reform Evaluation Programme. Following a supplementary call for research proposals in 2013, four new projects are commencing during the period October 2014 to January 2015.<\/p> <\/p> <\/p> <\/p> Expenditure by the Department on the Health Reform Evaluation Programme is shown in the following table.<\/p> <\/p> <\/p> <\/p> £ million<\/em><\/p> <\/p> 2009-10<\/p><\/td> 2010-11<\/p><\/td> 2011-12<\/p><\/td> 2012-13<\/p><\/td> 2013-14<\/p><\/td> 2014-15<\/p> Planned<\/p><\/td><\/tr> 1.5<\/p><\/td> 2.2<\/p><\/td> 2.0<\/p><\/td> 0.4<\/p><\/td> 0.0<\/p><\/td> 0.4<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-03T17:53:57.7640777Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Reorganisation"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much funding his Department allocated to the Health Reform Evaluation Programme for 2014-15; and how much was allocated in each of the five previous years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "tablingMemberConstituency" : {"_value" : "Denton and Reddish"}
, "tablingMemberPrinted" : [{"_value" : "Andrew Gwynne"}
], "uin" : "211976"}
, {"_about" : "http://data.parliament.uk/resources/101143", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/101143/answer", "answerText" : {"_value" : " The information is not collected because it could only be obtained at disproportionate cost.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-03T17:56:30.9311323Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Orphan Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much the NHS spent on orphan medicines in each of the last three years; and what proportion of total medicines expenditure that represented in each year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "tablingMemberConstituency" : {"_value" : "Denton and Reddish"}
, "tablingMemberPrinted" : [{"_value" : "Andrew Gwynne"}
], "uin" : "211977"}
, {"_about" : "http://data.parliament.uk/resources/101144", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/101144/answer", "answerText" : {"_value" : " The third round of national recruitment was one of the initiatives undertaken by Health Education England (HEE) to support recruitment into general practitioner (GP) training places. HEE continues to work with its partners to reach its mandate commitment of ensuring 3,250 trainees enter ST1 GP training by 2016.<\/p> <\/p> <\/p> <\/p> The estimated breakdown of costs is below:<\/p> <\/p> <\/p> <\/p> Description<\/p><\/td> Total<\/p><\/td><\/tr> Stage 2 Assessment<\/p><\/td> £10,000<\/p><\/td><\/tr> Stage 3 Venue<\/p><\/td> £24,230<\/p><\/td><\/tr> Printing costs<\/p><\/td> £893<\/p><\/td><\/tr> Assessors - clinical<\/p><\/td> £29,088<\/p><\/td><\/tr> Assessors - non-clinical<\/p><\/td> £3,636<\/p><\/td><\/tr> Moderators - clinical<\/p><\/td> £1,212<\/p><\/td><\/tr> Moderators - non clinical<\/p><\/td> £606<\/p><\/td><\/tr> Trainee expenses<\/p><\/td> £25,200<\/p><\/td><\/tr> Role Players<\/p><\/td> £18,920<\/p><\/td><\/tr> <\/p><\/td> £113,785<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> <\/strong><\/p> <\/p> <\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2014-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-03T16:41:24.5354323Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "General Practitioners"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what estimate he has made of the cost of Health Education England's third round of recruitment for general practice training posts.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "tablingMemberConstituency" : {"_value" : "Denton and Reddish"}
, "tablingMemberPrinted" : [{"_value" : "Andrew Gwynne"}
], "uin" : "211940"}
, {"_about" : "http://data.parliament.uk/resources/101145", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/101145/answer", "answerText" : {"_value" : " Over the course of the current spending review, we are investing in excess of £400 million in England to give thousands of people access to National Institute for Health and Care Excellence-approved psychological therapies, including Mindfulness-Based Cognitive Therapy.<\/p> <\/p> The 2014-15 Mandate to NHS England makes clear that \u2018everyone who needs it should have timely access to evidence based services\u2019. The Mandate sets a clear objective for NHS England to deliver the key objectives of the Improving Access to Psychological Therapy (IAPT) programme \u2013 providing access to therapies to 15% of those eligible (around 900,000 people) per year by 2015.<\/p> <\/p> <\/p> <\/p> We are increasing the availability of IAPT services to cover children and young people and exploring extending services to people with long-term physical health problems and those with severe mental illness.<\/p> <\/p> <\/p> <\/p> We have invested £54 million over the period 2011 \u2013 2015/16 in the Children and Young People\u2019s Improving Access to Psychological Therapies (CYP IAPT) programme. The Programme works with services covering up to 60% of England\u2019s 0-19 population, and will cover approximately 68% by the end of 2014-15. This is giving children and young people improved access to the best evidenced mental health care. NHS England is planning for a countrywide extension of the programme with Health Education England.<\/p> <\/p> <\/p> <\/p> The IAPT programme is working with a number of the Department\u2019s Strategic Partners to promote wider access of the service to all sections of the community. The partners are working with IAPT service providers to identify and overcome the barriers to people gaining access to IAPT services.<\/p> <\/p> <\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"}
}
, "answeringMemberConstituency" : {"_value" : "North Norfolk"}
, "answeringMemberPrinted" : {"_value" : "Norman Lamb"}
, "dateOfAnswer" : {"_value" : "2014-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-03T16:48:01.4098809Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Mental Health Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to improve access to NICE-recommended mindfulness-based therapies on the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/534", "label" : {"_value" : "Biography information for Chris Ruane"}
}
, "tablingMemberConstituency" : {"_value" : "Vale of Clwyd"}
, "tablingMemberPrinted" : [{"_value" : "Chris Ruane"}
], "uin" : "211947"}
, {"_about" : "http://data.parliament.uk/resources/101146", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/101146/answer", "answerText" : {"_value" : " Whilst recognising the work of blood bikes, the Department is not actively promoting their use as it is a matter for individual trusts to decide whether they wish to use such services.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-03T17:57:26.9540538Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Blood: Transport"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to promote the use of blood bikes for the transportation of blood to hospital trusts.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3925", "label" : {"_value" : "Biography information for Julie Hilling"}
}
, "tablingMemberConstituency" : {"_value" : "Bolton West"}
, "tablingMemberPrinted" : [{"_value" : "Julie Hilling"}
], "uin" : "212022"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=1&max-date=2014-10-27", "page" : 0, "startIndex" : 1, "totalResults" : 2701, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}